A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
Clinical trial NCT05308654 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05308654
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2024-02-07
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.